Fair Value Measurements

9 Months Ended

Dec. 29, 2012

Fair Value Measurements [Abstract]

Fair Value Measurements

18. Fair Value Measurements

The book value and estimated fair value of the Company’s financial instruments are as follows (in thousands):

	December 29, 2012				March 31, 2012
	Book		Estimated		Book		Estimated
	Value		Fair Value		Value		Fair Value
Cash and cash equivalents (1)	$	42,451	$	42,451	$	41,094	$	41,094
Restricted cash (1)		7,214		7,214		6,784		6,784
Investments (2)		16,506		16,506		14,202		14,202
Consumer loans receivable (3)		116,372		122,499		119,299		122,620
Interest rate lock commitment derivatives (4)		6		6		11		11
Forward loan sale commitment derivatives (4)		4		4		7		7
Inventory finance receivable (5)		25,877		25,877		24,681		24,681
Construction lending line (5)		—		—		4,550		4,550
Securitized financings (6)		84,524		84,274		91,475		94,765

⁽¹⁾  The fair value approximates book value due to the instruments’ short-term maturity.

⁽²⁾  The fair value is based on quoted market prices.

⁽³⁾  Includes consumer loans receivable held for investment, held for sale and construction advances. The fair value of the loans held for investment is based on the discounted value of the remaining principal and interest cash flows. The fair value of the loans held for sale are estimated based on recent GSE mortgage backed bond prices. The fair value of the construction advances approximates book value and the sales price of these loans is estimated based on construction completed.

⁽⁴⁾  The fair values are based on changes in GSE mortgage backed bond prices, and additionally for IRLCs, pull through rates.

⁽⁵⁾  The fair value approximates book value based on current market rates and the revolving nature of the instruments.

⁽⁶⁾  The fair value is estimated using recent public transactions of similar asset-backed securities.

In accordance with ASC 820, Fair Value Measurements and Disclosures (“ASC 820”), fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

Level 1 – Quoted prices in active markets for identical assets or liabilities.

Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company utilizes the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.

When the Company uses observable market prices for identical securities that are traded in less active markets, it classifies such securities as Level 2. When observable market prices for identical securities are not available, the Company prices its marketable debt instruments using non-binding market consensus prices that are corroborated with observable market data; quoted market prices for similar instruments; or pricing models, such as a discounted cash flow model, with all significant inputs derived from or corroborated with observable market data. Non-binding market consensus prices are based on the proprietary valuation models of pricing providers or brokers. These valuation models incorporate a number of inputs, including non-binding and binding broker quotes; observable market prices for identical or similar securities; and the internal assumptions of pricing providers or brokers that use observable market inputs and, to a lesser degree, unobservable market inputs.

Assets measured at fair value on a recurring basis are summarized below (in thousands):

	As of December 29, 2012
	Total		Level 1		Level 2		Level 3
Securities issued by the U.S Treasury and Government (1)	$	2,759	$	—	$	2,759	$	—
Mortgage-backed securities (1)		4,968		—		4,968		—
Securities issued by states and political subdivisions (1)		1,450		—		1,450		—
Corporate debt securities (1)		3,235		—		3,235		—
Marketable equity securities (1)		4,094		4,094		—		—
Interest rate lock commitment derivatives (2)		6		—		—		6
Forward loan sale commitment derivatives (2)		4		—		—		4

⁽¹⁾  Unrealized gains or losses on investments are recorded in accumulated other comprehensive income (loss) at each measurement date.

⁽²⁾  Gains or losses on derivatives are recognized in current period earnings through cost of sales.

No transfers between Level 1, Level 2 or Level 3 occurred during the nine months ended December 29, 2012. The Company’s policy regarding the recording of transfers between levels is to record any such transfers at the end of the reporting period.

Assets and liabilities for which fair value is disclosed but not required to be recognized in the balance sheet on a recurring basis are summarized below (in thousands):

	As of December 29, 2012
	Total		Level 1		Level 2		Level 3
Cash and cash equivalents	$	42,451	$	42,451	$	—	$	—
Restricted cash		7,214		7,214		—		—
Loans held for investment		108,425		—		—		108,425
Loans held for sale		8,268		—		8,268		—
Loans held—construction advances		5,806		—		—		5,806
Inventory finance receivable		25,877		—		—		25,877
Securitized financings		84,274		—		84,274		—

The Company records impairment losses on long-lived assets held for sale when the fair value of such long-lived assets is below their carrying values. The Company records impairment charges on long-lived assets used in operations when events and circumstances indicate that long-lived assets might be impaired and the undiscounted cash flows estimated to be generated by those assets are less than their carrying amounts. The Company recorded no impairment charges on assets held for sale or used in operations during the nine months ended December 29, 2012.

Assets measured on a nonrecurring basis also include impaired loans (nonaccrual loans) disclosed in Note 5 and loans held for sale. No recent sales have been executed in an orderly market of manufactured home loan portfolios with comparable product features, credit characteristics, or performance. Impaired loans are measured using Level 3 inputs that are calculated using estimated discounted future cash flows with discount rates considered to reflect current market conditions. Loans held for sale are measured at the lower of cost or fair value using Level 2 inputs that consist of commitments on hand from investors. These loans are held for relatively short periods, typically no more than 45 days. As a result, changes in loan-specific credit risk are not a significant component of the change in fair value. The cost of loans held for sale is lower than the fair value as of December 29, 2012.

ASC 825, Financial Instruments (“ASC 825”), requires disclosure of fair value information about financial instruments, whether or not recognized in the balance sheet, for which it is practicable to estimate fair value. Fair value estimates are made as of a specific point in time based on the characteristics of the financial instruments and the relevant market information. Where available, quoted market prices are used. In other cases, fair values are based on estimates using other valuation techniques. These techniques involve uncertainties and are significantly affected by the assumptions used and the judgments made regarding risk characteristics of various financial instruments, discount rates, estimates of future cash flows, future expected loss experience, and other factors. Changes in assumptions could significantly affect these estimates and the resulting fair values. Derived fair value estimates cannot be substantiated by comparison to independent markets and, in many cases, could not be realized in an immediate sale of the instrument. Also, because of differences in methodologies and assumptions used to estimate fair values, the Company’s fair values should not be compared to those of other companies.

Under ASC 825, fair value estimates are based on existing financial instruments without attempting to estimate the value of anticipated future business and the value of assets and liabilities that are not considered financial instruments. Accordingly, the aggregate fair value amounts presented do not represent the underlying market value of the Company.